deltatrials
Completed OBSERVATIONAL NCT01387802

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete-AS)

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete - AS)

Sponsor: AbbVie (prior sponsor, Abbott)

Conditions Ankylosing Spondylitis
Updated 15 times since 2017 Last updated: Dec 7, 2020 Started: Jun 29, 2011 Primary completion: Dec 16, 2019 Completion: Dec 16, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01387802, this observational or N/A phase trial focuses on Ankylosing Spondylitis and remains completed. Sponsored by AbbVie (prior sponsor, Abbott), it has been updated 15 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Jan 2018 · 5 months · monthly snapshot~Jan 2018 – ~Mar 2018 · 59 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Jul 2019 · 7 months · monthly snapshot~Jul 2019 – ~Feb 2020 · 7 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Feb 2020 — Jan 2021 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

▶ Show 10 earlier versions

  1. Jul 2019 — Feb 2020 [monthly]

    Active Not Recruiting

  2. Dec 2018 — Jul 2019 [monthly]

    Active Not Recruiting

  3. Aug 2018 — Dec 2018 [monthly]

    Active Not Recruiting

  4. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  5. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  6. Mar 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

  7. Jan 2018 — Mar 2018 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  8. Aug 2017 — Jan 2018 [monthly]

    Recruiting NA

  9. May 2017 — Aug 2017 [monthly]

    Recruiting NA

  10. Jan 2017 — May 2017 [monthly]

    Recruiting NA

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AbbVie (prior sponsor, Abbott)
  • Cato Research
  • JSS Medical Research Inc.
Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ancaster, Canada , Barrie, Canada , Brampton, Canada , Brockville, Canada , Burlington, Canada , Calgary, Canada , Cranbrook, Canada , Dundas, Canada , Fredericton, Canada , Halifax, Canada and 28 more locations